NasdaqGS - Delayed Quote USD

23andMe Holding Co. (ME)

0.4641 +0.0051 (+1.11%)
At close: April 26 at 4:00 PM EDT
0.4637 -0.00 (-0.09%)
After hours: April 26 at 7:39 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
247,987.0000
299,489.0000
271,893.0000
243,920.0000
Cost of Revenue
135,660.0000
164,993.0000
138,948.0000
126,914.0000
Gross Profit
112,327.0000
134,496.0000
132,945.0000
117,006.0000
Operating Expense
444,038.0000
458,507.0000
387,098.0000
302,202.0000
Operating Income
-331,711.0000
-324,011.0000
-254,153.0000
-185,196.0000
Net Non Operating Interest Income Expense
15,658.0000
9,676.0000
277.0000
255.0000
Other Income Expense
-206,493.0000
-93.0000
32,906.0000
1,322.0000
Pretax Income
-522,546.0000
-314,428.0000
-220,970.0000
-183,619.0000
Tax Provision
-578.0000
-2,772.0000
-3,480.0000
--
Net Income Common Stockholders
-521,968.0000
-311,656.0000
-217,490.0000
-183,619.0000
Diluted NI Available to Com Stockholders
-521,968.0000
-311,656.0000
-217,490.0000
-183,619.0000
Basic EPS
-1.11
-0.69
-0.60
-0.45
Diluted EPS
-1.11
-0.69
-0.60
-0.45
Basic Average Shares
468,554.4200
451,504.3770
361,528.1190
406,414.8390
Diluted Average Shares
468,554.4200
451,504.3770
361,528.1190
406,414.8390
Total Operating Income as Reported
-538,879.0000
-324,011.0000
-254,153.0000
-185,196.0000
Total Expenses
579,698.0000
623,500.0000
526,046.0000
429,116.0000
Net Income from Continuing & Discontinued Operation
-521,968.0000
-311,656.0000
-217,490.0000
-183,619.0000
Normalized Income
-315,029.1532
-311,656.0000
-249,819.2200
-183,619.0000
Interest Income
15,658.0000
9,676.0000
277.0000
255.0000
Net Interest Income
15,658.0000
9,676.0000
277.0000
255.0000
EBIT
-331,711.0000
-324,011.0000
-254,153.0000
-185,196.0000
EBITDA
-299,800.0000
-287,513.0000
-228,005.0000
-164,950.0000
Reconciled Cost of Revenue
112,950.0000
150,945.0000
118,386.0000
126,914.0000
Reconciled Depreciation
31,911.0000
36,498.0000
26,148.0000
20,246.0000
Net Income from Continuing Operation Net Minority Interest
-521,968.0000
-311,656.0000
-217,490.0000
-183,619.0000
Total Unusual Items Excluding Goodwill
-207,168.0000
--
32,989.0000
--
Total Unusual Items
-207,168.0000
--
32,989.0000
--
Normalized EBITDA
-92,632.0000
-287,513.0000
-260,994.0000
-164,950.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
--
Tax Effect of Unusual Items
-229.1532
--
659.7800
--
3/31/2021 - 11/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TTOO T2 Biosystems, Inc.
2.8400
+3.65%
 
ISPC iSpecimen Inc.
0.2660
-5.07%
 
ILMN Illumina, Inc.
122.28
+1.02%
 
GH Guardant Health, Inc.
17.35
+1.11%
 
NVTAQ Invitae Corporation
0.0005
-94.44%
 
EXAS Exact Sciences Corporation
58.85
+0.10%
 
LAB Standard BioTools Inc.
2.4400
+3.39%
 
VNRX VolitionRx Limited
0.9137
+2.65%
 
APDN Applied DNA Sciences, Inc.
4.3700
-12.60%
 
TWST Twist Bioscience Corporation
31.54
+1.48%